| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 42 |
| 1 | METHOTREXATE | 41 |
| 2 | ADALIMUMAB | 35 |
| 3 | LEVETIRACETAM | 31 |
| 4 | CARBOPLATIN | 24 |
| 5 | CYCLOPHOSPHAMIDE | 22 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 22 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 22 |
| 8 | LEVETIRACETAM IN SODIUM CHLORIDE | 22 |
| 9 | LEVETIRACETAM INJECTION | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 13 | 0.0903 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 17 | 0.0688 |
| 2 | CHLORPROMAZINE HYDROCHLORIDE | 11 | 0.0115 |
| 3 | INDOCYANINE GREEN | 1 | 0.0083 |
| 4 | FLOXURIDINE | 1 | 0.0058 |
| 5 | HYDRALAZINE HYDROCHLORIDE | 10 | 0.0037 |
| 6 | METHYLDOPA | 17 | 0.0034 |
| 7 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 8 | NALOXONE HCL | 2 | 0.0023 |
| 9 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 56 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 47 |
| 2 | Benzodiazepine [EPC] | 46 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 4 | Alkylating Drug [EPC] | 35 |
| 5 | Platinum-based Drug [EPC] | 30 |
| 6 | Anti-epileptic Agent [EPC] | 28 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 23 |
| 8 | Atypical Antipsychotic [EPC] | 22 |
| 9 | Azole Antifungal [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Allylamine Antifungal [EPC] | 6 | 0.0008 |
| 3 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 4 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 5 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 6 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 7 | Anthelmintic [EPC] | 1 | 0.0003 |
| 8 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |